| CYSB2400058 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-03-01 | | China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd | | | view |
| CXSL2200012 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-01-12 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
| CXSL2400412 | 静注人免疫球蛋白（pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products(3.2) | New Drug Application | 2024-06-26 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2200136 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2022-06-07 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CXSL2200230 | 静注人免疫球蛋白 | Human Immunoglobulin(pH4) | Injection | Biological Products(3.2) | New Drug Application | 2022-05-27 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
| CXSL2200604 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-12-16 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
| CYSB2101109 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2021-07-13 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2400098 | 静注人免疫球蛋白（pH4） | Human Immunoglobulin(pH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-04-25 | | Green Cross China Biological Products Co Ltd | | | view |
| CYSB2200135 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2022-06-07 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2200070 | 静注人免疫球蛋白（pH4） | Human Immunoglobulin(pH4) | Injection | Biological Products(原15) | Supplementary Application | 2022-03-10 | | Green Cross China Biological Products Co Ltd | | | view |
| CYSB2101072 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2021-05-24 | | Hualan Biological Engineering Inc | | | view |
| CYSB2400114 | 静注人免疫球蛋白（pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2024-05-15 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2200240 | 静注人免疫球蛋白（10%） | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2022-10-10 | | Guizhou Taibang Biological Products Co Ltd | | | view |
| CYSB2101160 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2021-08-18 | | Hualan Biological Engineering Inc | | | view |
| CYSB2200138 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2022-06-07 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CXSL2400234 | 静注人免疫球蛋白（pH4） | Human Immunoglobulin(pH4) | Injection | Biological Products(3.4) | New Drug Application | 2024-04-16 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2200065 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2022-03-01 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
| CYSB2200109 | 静注人免疫球蛋白（pH4） | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2022-04-29 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101142 | 静注人免疫球蛋白(pH4) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2300149 | 静注人免疫球蛋白(10%) | Human Immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2023-08-02 | | Guangdong Shuanglin Bio-Pharmacy Co Ltd | | | view |
